Exelixis
EXEL
#1546
Rank
A$20.47 B
Marketcap
A$82.65
Share price
1.55%
Change (1 day)
45.47%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company